4.0
5 Sept 2016
Former employee, more than 10 years
London, England
Recommend
CEO approval
Business outlook
Pros
Patient focused; research centric; finding good drugs to make people feel better and live longer. Seems to have ridden recent storms around compliance, key drugs going off patent, and sharp practices reasonably well
Cons
Downward pressure on costs in support services such as IT is relentless. Now seems to be all about money and quality, customer service etc takes second place. That said, maybe it's the right strategy. Time will tell